CDK1 and cancer: That the latter explanation is correct was recently demonstrated by elegant genetic studies in human non-transformed and cancer cells, in which single and double CDK1 and CDK2 degron mutants were superimposed onto a CRISPR-Cas9-mediated knockout background for each kinase, and CDK1, CDK2 or both were then acutely depleted [98].